Gene · 28906
Papers1,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of the glycoproteins of fish and amphibian influenza B-like viruses. | Sci Adv | 2025 | 40845102 | PubTator, text mining | PubMed |
| Inhibitory effects of β-galactoside α2,6-sialyltransferase 1 on the Hippo pathway in breast cancer cells. | J Biol Chem | 2025 | 40409546 | PubTator, text mining | PubMed |
| Glycosyltransferases: glycoengineers in human milk oligosaccharide synthesis and manufacturing. | Front Mol Biosci | 2025 | 40370521 | PubTator, text mining | PubMed |
| Host and bacterial urine proteomics might predict treatment outcomes for immunotherapy in advanced non-small cell lung cancer patients. | Front Immunol | 2025 | 40297587 | PubTator, text mining | PubMed |
| Compositional and topological determinants of a physiological Ashwell-Morell receptor ligand. | Proc Natl Acad Sci U S A | 2025 | 40208943 | PubTator, text mining | PubMed |
| Scoping review protocol: The chrononutrition factors in association with glycemic outcomes in adult population. | PLoS One | 2025 | 39951411 | PubTator, text mining | PubMed |
| Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinoma. | BBA Adv | 2025 | 39911812 | PubTator, text mining | PubMed |
| The sweet side of H5N1 influenza virus infection. | PLoS Pathog | 2025 | 39847560 | PubTator, text mining | PubMed |
| ST6GAL1-Mediated Sialylation of PECAM-1 Promotes a Transcellular Diapedesis-Like Process That Directs Lung Tropism of Metastatic Breast Cancer. | Cancer Res | 2025 | 39786386 | PubTator, text mining | PubMed |
| Salivary adenoid cystic carcinoma-derived α2,6-sialylated extracellular vesicles increase vascular permeability by triggering ER-stress in endothelial cells and promote lung metastasis. | Cancer Lett | 2025 | 39710056 | PubTator, text mining | PubMed |
| Apoptotic signaling by TNFR1 is inhibited by the α2-6 sialylation, but not α2-3 sialylation, of the TNFR1 N-glycans. | J Biol Chem | 2025 | 39615678 | PubTator, text mining | PubMed |
| Structural and quantitative comparison of viral infection-associated N-glycans in plasma from humans, pigs, and chickens: Greater similarity between humans and chickens than pigs. | Antiviral Res | 2024 | 39326504 | PubTator, text mining | PubMed |
| Theoretical Investigations of a point mutation affecting H5 Hemagglutinin's receptor binding preference. | Comput Biol Chem | 2024 | 39216409 | PubTator, text mining | PubMed |
| Targeting Tumor-Associated Sialic Acids Using Chimeric Switch Receptors Based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T Cells. | Cancer Immunol Res | 2024 | 39037052 | PubTator, text mining | PubMed |
| Evolving roles of glycosylation in the tug-of-war between virus and host. | Natl Sci Rev | 2024 | 38784919 | PubTator, text mining | PubMed |
| Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone. | EBioMedicine | 2024 | 38772281 | PubTator, text mining | PubMed |
| N-linked α2,6-sialylation of integrin β1 by the sialyltransferase ST6Gal1 promotes cell proliferation and stemness in gestational trophoblastic disease. | Placenta | 2024 | 38490094 | PubTator, text mining | PubMed |
| Impaired influenza A virus replication by the host restriction factor SAMHD1 which inhibited by PA-mediated dephosphorylation of the host transcription factor IRF3. | Virol J | 2024 | 38287375 | PubTator, text mining | PubMed |
| Designing transparent piezoelectric metasurfaces for adaptive optics. | Nat Commun | 2024 | 38280898 | PubTator, text mining | PubMed |
| Altered O-linked glycosylation in benign and malignant meningiomas. | PeerJ | 2024 | 38274327 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28906/papers?page=3